Humacyte Inc

Research Humacyte Inc (HUMA) on Bullrun: market cap USD 177.37M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerHUMA
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 177.37M
• Financial periodFY2025
• RevenueUSD 2.04M
• Net income-USD 40.83M
• Free cash flow-USD 105.93M
• Gross margin-376.1%

Valuation Snapshot

latest market cap is USD 177.37M.

About Humacyte Inc

Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection.

Frequently asked questions

What is Humacyte Inc's market cap?

Humacyte Inc's market capitalization is USD 177.37M.

What does Humacyte Inc do?

Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas.